Brief: Veru Submits IND Application to FDA for Development of Enobosarm

Veru

08/01/2024 17:53

Jan 8 (Reuters) - Veru Inc  VERU.O :
    * VERU SUBMITS IND APPLICATION TO FDA FOR THE DEVELOPMENT OF
ENOBOSARM TO PREVENT MUSCLE LOSS WHILE AUGMENTING FAT LOSS IN
COMBINATION WITH GLP-1 DRUGS FOR WEIGHT LOSS
    * VERU INC: PLANS TO CONDUCT A PHASE 2B MULTICENTER,
DOUBLE-BLIND,
PLACEBO-CONTROLLED, RANDOMIZED, DOSE-FINDING CLINICAL TRIAL
    * VERU INC- PRIMARY 3-MONTH CLINICAL DATA FROM PHASE 2B
CLINICAL
TRIAL IS CURRENTLY EXPECTED IN CALENDAR Q4 2024

Source text for Eikon:  ID:nGNX4fQHBZ 
Further company coverage:  VERU.O 

 ((Reuters.Briefs@thomsonreuters.com;))